API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KQ /
  3. 215600.KQ

SillaJen Inc (215600 KQ) stock market data APIs

₩2605 -325(-11.1%) as of November 25, 2024
Price chart is built with Anychart

SillaJen, Inc. develops and commercializes oncolytic immunotherapy products in South Korea. Its lead product is Pexa-Vec for the treatment of advanced liver cancer. The company also develops BAL0891, a dual TTK/PLK inhibitor; SJ-600 to improve the intravenous administration efficiency of anticancer viruses; JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. SillaJen, Inc. was founded in 2006 and is headquartered in Seoul, South Korea.

SillaJen Inc Financial Data Overview

2930
2605
-
3010
2605
2340-6719.6646
356 959 M
137 M
1 657 M
-57.3042
-0.018
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '215600',
Type: 'Common Stock',
Name: 'SillaJen Inc',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG00F5P6RC6',
ISIN: 'KR7215600008',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

SillaJen Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 657 M
  • EBITDA -22 566 467 584
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get SillaJen Inc Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast NaN

Get SillaJen Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get SillaJen Inc latest news via APIs

Basilea announces acquisition of rights for oncology asset BAL0891 by SillaJen and updates financial guidance

Upfront and near-term milestone payments of USD 14 million Additional milestone payments of approximately USD 320 million and tiered royalties on net salesSecond oncology transaction as part of strate...
  • BASILEA PHARMACEUTICA AG
  • COMPANY ANNOUNCEMENT
  • EUROPEAN REGULATORY NEWS
  • SWISS STOCK EXCHANGE:BSLN

Basilea announces acquisition of rights for oncology asset BAL0891 by SillaJen and updates financial guidance

Basilea Pharmaceutica AG Upfront and near-term milestone payments of USD 14 million Additional milestone payments of approximately USD 320 million and tiered royalties on net sales Second oncology t...
  • ASSET PURCHASE AGREEMENT
  • BASILEA PHARMACEUTICA
  • BASILEA PHARMACEUTICA LTD
  • BIOPHARMACEUTICAL COMPANY
  • CELL DIVISION
  • COLLABORATION AGREEMENT
  • FUNGAL INFECTIONS
  • INC
  • KINASE INHIBITOR
  • NTRC
  • PRECLINICAL DEVELOPMENT
  • SILLAJEN
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com